_id
691c3ca21d3bbaa0018aba42
Ticker
BGM
Name
Qilian International Holding Group Limited
Exchange
NASDAQ
Address
No. 152 Hongliang East 1st Street, Chengdu, China, 610200
Country
USA
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
USD
Website
https://www.bgm.ltd
Description
BGM Group Ltd manufactures and distributes active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company provides licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, a primary ingredient for medical preparation companies to produce compound licorice oral solutions. It offers Qilian Shan oxytetracycline tablets to prevent and treat a range of diseases in chickens, turkeys, cattle, swine, and human; and Qilian Shan oxytetracycline APIs for pharmaceutical companies to manufacture medications. In addition, the company offers TCMD products, such as Ahan antibacterial paste to treat refractory chronic skin diseases; heparin products, including heparin sodium preparations for pharmaceutical companies to produce medications for cardiovascular diseases, cerebrovascular diseases, and hemodialysis; and Zhu Xiaochang sausage casings, which are natural food products for culinary application. Further, it provides Xiongguan organic fertilizers to improve crop yield and soil's chemical properties and reduce soil compaction; and Xiongguan organic-inorganic compound fertilizers to increased plant growth. The company was formerly known as Qilian International Holding Group Limited and changed its name to BGM Group Ltd in October 2024. BGM Group Ltd was incorporated in 2019 and is based in Chengdu, the People's Republic of China.
Last Close
3.715
Volume
1059
Current Price
3.73
Change
0.01
Last Updated
2026-01-20T16:29:42.487Z
Image
data:image/webp;base64,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
Ipo Date
2024-08-12T00:00:00.000Z
Market Cap
746318912
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2024-03-31
Revenue
12562599
Cost Of Revenue
11148577
Gross Profit
1414022
Operating Expenses
2093110
Operating Income
-679088
Interest Expense
-
Pretax Income
340716
Net Income
328780
Eps
0.045496562641839454
Dividends Per Share
-
Shares Outstanding
180623358
Income Tax Expense
11936
EBITDA
-679088
Operating Margin
-5.405633022275088
Total Other Income Expense Net
1019804
Cash
10345332
Short Term Investments
15009946
Receivables
2723526
Inventories
4650721
Total Current Assets
33326420
Property Plant Equipment
13095979
Total Assets
49852370
Payables
2672052
Short Term Debt
83089
Long Term Debt
-
Total Liabilities
4931396
Equity
43431859
Bs_currency_symbol
USD
Depreciation
-
Change In Working Capital
-
Cash From Operations
-
Capital Expenditures
-
Cash From Investing
-
Cash From Financing
-
Net Change In Cash
-
Cf_currency_symbol
-
PE
-
PB
0.6206220737638699
ROE
0.7570019049840809
ROA
0.6595072611392397
FCF
-
Fcf Percent
-
Piotroski FScore
2
Health Score
57
Deep Value Investing Score
7.5
Defensive Investing Score
6
Dividend Investing Score
1.5
Economic Moat Investing Score
3.3
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
1
Net Net Investing Score
2.5
Quality Investing Score
3
Value Investing Score
8
Quarters > 0 > quarter
2024-03-31
Quarters > 0 > income Statement > revenue
12562599
Quarters > 0 > income Statement > cost Of Revenue
11148577
Quarters > 0 > income Statement > gross Profit
1414022
Quarters > 0 > income Statement > operating Expenses
2093110
Quarters > 0 > income Statement > operating Income
-679088
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
340716
Quarters > 0 > income Statement > net Income
328780
Quarters > 0 > income Statement > eps
0.045496562641839454
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
7226480
Quarters > 0 > income Statement > income Tax Expense
11936
Quarters > 0 > income Statement > EBITDA
-679088
Quarters > 0 > income Statement > operating Margin
-5.405633022275088
Quarters > 0 > income Statement > total Other Income Expense Net
1019804
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
10345332
Quarters > 0 > balance Sheet > short Term Investments
15009946
Quarters > 0 > balance Sheet > receivables
2723526
Quarters > 0 > balance Sheet > inventories
4650721
Quarters > 0 > balance Sheet > total Current Assets
33326420
Quarters > 0 > balance Sheet > property Plant Equipment
13095979
Quarters > 0 > balance Sheet > total Assets
49852370
Quarters > 0 > balance Sheet > payables
2672052
Quarters > 0 > balance Sheet > short Term Debt
83089
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
4931396
Quarters > 0 > balance Sheet > equity
43431859
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-
Quarters > 0 > cash Flow > depreciation
-
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-
Quarters > 0 > cash Flow > capital Expenditures
-
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-
Quarters > 0 > cash Flow > net Change In Cash
-
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
0.045496562641839454
Quarters > 0 > ratios > PB
0.6206220737638699
Quarters > 0 > ratios > ROE
0.7570019049840809
Quarters > 0 > ratios > ROA
0.6595072611392397
Quarters > 0 > ratios > FCF
-
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
57
Annuals > 0 > quarter
2024-09-30
Annuals > 0 > income Statement > revenue
25097951
Annuals > 0 > income Statement > cost Of Revenue
20983196
Annuals > 0 > income Statement > gross Profit
4114755
Annuals > 0 > income Statement > operating Expenses
4678526
Annuals > 0 > income Statement > operating Income
-563771
Annuals > 0 > income Statement > interest Expense
639511
Annuals > 0 > income Statement > pretax Income
-2137142
Annuals > 0 > income Statement > net Income
-1442830
Annuals > 0 > income Statement > eps
-0.19965875502319247
Annuals > 0 > income Statement > dividends Per Share
0
Annuals > 0 > income Statement > shares Outstanding
7226480
Annuals > 0 > income Statement > income Tax Expense
-619981
Annuals > 0 > income Statement > EBITDA
879873
Annuals > 0 > income Statement > operating Margin
-2.24628297345867
Annuals > 0 > income Statement > total Other Income Expense Net
-1573371
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
9817254
Annuals > 0 > balance Sheet > short Term Investments
8323587
Annuals > 0 > balance Sheet > receivables
5774757
Annuals > 0 > balance Sheet > inventories
5049688
Annuals > 0 > balance Sheet > total Current Assets
29769210
Annuals > 0 > balance Sheet > property Plant Equipment
14910911
Annuals > 0 > balance Sheet > total Assets
53003728
Annuals > 0 > balance Sheet > payables
4125597
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
8910379
Annuals > 0 > balance Sheet > equity
42743844
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-1517161
Annuals > 0 > cash Flow > depreciation
1237229
Annuals > 0 > cash Flow > change In Working Capital
785703
Annuals > 0 > cash Flow > cash From Operations
544238
Annuals > 0 > cash Flow > capital Expenditures
3931471
Annuals > 0 > cash Flow > cash From Investing
983418
Annuals > 0 > cash Flow > cash From Financing
-491728
Annuals > 0 > cash Flow > net Change In Cash
2341007
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-0.19965875502319247
Annuals > 0 > ratios > PB
0.6306117531216893
Annuals > 0 > ratios > ROE
-3.3755270115621796
Annuals > 0 > ratios > ROA
-2.722129281170562
Annuals > 0 > ratios > FCF
-3387233
Annuals > 0 > ratios > Piotroski FScore
2
Annuals > 0 > ratios > fcf Percent
-0.13496053920895773
Annuals > 0 > health Score
35
Annuals > 1 > quarter
2023-09-30
Annuals > 1 > income Statement > revenue
46471478
Annuals > 1 > income Statement > cost Of Revenue
44719984
Annuals > 1 > income Statement > gross Profit
1751494
Annuals > 1 > income Statement > operating Expenses
4361593
Annuals > 1 > income Statement > operating Income
-2610099
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-7902904
Annuals > 1 > income Statement > net Income
-7780620
Annuals > 1 > income Statement > eps
-1.0766818700114025
Annuals > 1 > income Statement > dividends Per Share
1787517
Annuals > 1 > income Statement > shares Outstanding
7226480
Annuals > 1 > income Statement > income Tax Expense
219166
Annuals > 1 > income Statement > EBITDA
-1274660
Annuals > 1 > income Statement > operating Margin
-5.616561194804262
Annuals > 1 > income Statement > total Other Income Expense Net
-5292805
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
7476247
Annuals > 1 > balance Sheet > short Term Investments
14943019
Annuals > 1 > balance Sheet > receivables
6354589
Annuals > 1 > balance Sheet > inventories
4991435
Annuals > 1 > balance Sheet > total Current Assets
34512621
Annuals > 1 > balance Sheet > property Plant Equipment
12705008
Annuals > 1 > balance Sheet > total Assets
51257994
Annuals > 1 > balance Sheet > payables
3592687
Annuals > 1 > balance Sheet > short Term Debt
553275
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
6906593
Annuals > 1 > balance Sheet > equity
42792133
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-8122070
Annuals > 1 > cash Flow > depreciation
1143064
Annuals > 1 > cash Flow > change In Working Capital
1112186
Annuals > 1 > cash Flow > cash From Operations
312209
Annuals > 1 > cash Flow > capital Expenditures
3714089
Annuals > 1 > cash Flow > cash From Investing
-4742445
Annuals > 1 > cash Flow > cash From Financing
-2921084
Annuals > 1 > cash Flow > net Change In Cash
-7502766
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-1.0766818700114025
Annuals > 1 > ratios > PB
0.6299001360834244
Annuals > 1 > ratios > ROE
-18.182360762432666
Annuals > 1 > ratios > ROA
-15.17932988169611
Annuals > 1 > ratios > FCF
-3401880
Annuals > 1 > ratios > Piotroski FScore
2
Annuals > 1 > ratios > fcf Percent
-0.07320361104073342
Annuals > 1 > health Score
35
Annuals > 2 > quarter
2022-09-30
Annuals > 2 > income Statement > revenue
64855025
Annuals > 2 > income Statement > cost Of Revenue
58627728
Annuals > 2 > income Statement > gross Profit
6227297
Annuals > 2 > income Statement > operating Expenses
4125294
Annuals > 2 > income Statement > operating Income
2102003
Annuals > 2 > income Statement > interest Expense
-
Annuals > 2 > income Statement > pretax Income
1560559
Annuals > 2 > income Statement > net Income
1076693
Annuals > 2 > income Statement > eps
0.14899273228459775
Annuals > 2 > income Statement > dividends Per Share
0
Annuals > 2 > income Statement > shares Outstanding
7226480
Annuals > 2 > income Statement > income Tax Expense
194302
Annuals > 2 > income Statement > EBITDA
3740392
Annuals > 2 > income Statement > operating Margin
3.2410796233599477
Annuals > 2 > income Statement > total Other Income Expense Net
-541444
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
14319234
Annuals > 2 > balance Sheet > short Term Investments
0
Annuals > 2 > balance Sheet > receivables
4871658
Annuals > 2 > balance Sheet > inventories
8879486
Annuals > 2 > balance Sheet > total Current Assets
30033989
Annuals > 2 > balance Sheet > property Plant Equipment
12291943
Annuals > 2 > balance Sheet > total Assets
64526617
Annuals > 2 > balance Sheet > payables
5289481
Annuals > 2 > balance Sheet > short Term Debt
1696086
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
9563081
Annuals > 2 > balance Sheet > equity
53052142
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
1366257
Annuals > 2 > cash Flow > depreciation
1224672
Annuals > 2 > cash Flow > change In Working Capital
8751332
Annuals > 2 > cash Flow > cash From Operations
12654188
Annuals > 2 > cash Flow > capital Expenditures
3258952
Annuals > 2 > cash Flow > cash From Investing
-3258952
Annuals > 2 > cash Flow > cash From Financing
-5937529
Annuals > 2 > cash Flow > net Change In Cash
2371640
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
0.14899273228459775
Annuals > 2 > ratios > PB
0.5080807180226578
Annuals > 2 > ratios > ROE
2.0294995817511006
Annuals > 2 > ratios > ROA
1.668602896073104
Annuals > 2 > ratios > FCF
9395236
Annuals > 2 > ratios > Piotroski FScore
4
Annuals > 2 > ratios > fcf Percent
0.14486519741531206
Annuals > 2 > health Score
66
Annuals > 3 > quarter
2021-09-30
Annuals > 3 > income Statement > revenue
57099884
Annuals > 3 > income Statement > cost Of Revenue
51461354
Annuals > 3 > income Statement > gross Profit
5638530
Annuals > 3 > income Statement > operating Expenses
3250485
Annuals > 3 > income Statement > operating Income
2388045
Annuals > 3 > income Statement > interest Expense
57671
Annuals > 3 > income Statement > pretax Income
3363277
Annuals > 3 > income Statement > net Income
3152868
Annuals > 3 > income Statement > eps
0.46244267076883544
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
6817857
Annuals > 3 > income Statement > income Tax Expense
255133
Annuals > 3 > income Statement > EBITDA
4153372
Annuals > 3 > income Statement > operating Margin
4.182223907845417
Annuals > 3 > income Statement > total Other Income Expense Net
975232
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
10467357
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
13469492
Annuals > 3 > balance Sheet > inventories
12495831
Annuals > 3 > balance Sheet > total Current Assets
40365153
Annuals > 3 > balance Sheet > property Plant Equipment
11481278
Annuals > 3 > balance Sheet > total Assets
75353263
Annuals > 3 > balance Sheet > payables
6643691
Annuals > 3 > balance Sheet > short Term Debt
7922865
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
18684805
Annuals > 3 > balance Sheet > equity
54858606
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
3108144
Annuals > 3 > cash Flow > depreciation
1201229
Annuals > 3 > cash Flow > change In Working Capital
-3671809
Annuals > 3 > cash Flow > cash From Operations
345034
Annuals > 3 > cash Flow > capital Expenditures
3493374
Annuals > 3 > cash Flow > cash From Investing
-24200032
Annuals > 3 > cash Flow > cash From Financing
23993338
Annuals > 3 > cash Flow > net Change In Cash
740243
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
0.46244267076883544
Annuals > 3 > ratios > PB
0.46356640214299283
Annuals > 3 > ratios > ROE
5.747262334737416
Annuals > 3 > ratios > ROA
4.184116087978832
Annuals > 3 > ratios > FCF
-3148340
Annuals > 3 > ratios > Piotroski FScore
4
Annuals > 3 > ratios > fcf Percent
-0.055137414990195074
Annuals > 3 > health Score
59
Valuation > metrics > PE
0.045496562641839454
Valuation > metrics > PB
0.6206220737638699
Valuation > final Score
90
Valuation > verdict
68.7% Undervalued
Profitability > metrics > ROE
0.7570019049840809
Profitability > metrics > ROA
0.9865446093519796
Profitability > metrics > Net Margin
0.026171336042804517
Profitability > final Score
8
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.11354328627747663
Risk > metrics > Interest Coverage
-0.6659005063718126
Risk > final Score
57
Risk > verdict
High
Liquidity > metrics > Current Ratio
12.096085100544764
Liquidity > metrics > Quick Ratio
10.408069496261716
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
0
Prev Valuations > 1
0
Prev Valuations > 2
0
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
0
Prev Risks > 1
0
Prev Risks > 2
0
Prev Liquidities > 0
0
Prev Liquidities > 1
0
Prev Liquidities > 2
0
Updated At
2026-01-20T23:11:56.507Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-01-22
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-07-24
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.03
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
-0.03
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2023-03-31
Earnings History > 2 > report Date
2023-04-19
Earnings History > 2 > date
2023-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
0.03
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
0.03
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2022-06-30
Earnings History > 3 > report Date
2022-09-30
Earnings History > 3 > date
2022-06-30
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
0
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2021-12-31
Earnings History > 4 > report Date
2022-02-11
Earnings History > 4 > date
2021-12-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
0.02
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
0.02
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2021-06-30
Earnings History > 5 > report Date
2021-09-16
Earnings History > 5 > date
2021-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
-
Earnings History > 5 > eps Actual
0.07
Earnings History > 5 > eps Estimate
0
Earnings History > 5 > eps Difference
0.07
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2020-12-31
Earnings History > 6 > report Date
2021-02-11
Earnings History > 6 > date
2020-12-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
-
Earnings History > 6 > eps Actual
0.14
Earnings History > 6 > eps Estimate
0
Earnings History > 6 > eps Difference
0.14
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2020-09-30
Earnings History > 7 > report Date
2020-12-23
Earnings History > 7 > date
2020-09-30
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
-
Earnings History > 7 > eps Actual
0.15
Earnings History > 7 > eps Estimate
0
Earnings History > 7 > eps Difference
0.15
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2019-09-30
Earnings History > 8 > report Date
2019-11-04
Earnings History > 8 > date
2019-09-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
-
Earnings History > 8 > eps Actual
0.15
Earnings History > 8 > eps Estimate
0
Earnings History > 8 > eps Difference
0.15
Earnings History > 8 > surprise Percent
-
BGM Group Ltd manufactures and distributes active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company provides licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, a primary ingredient for medical preparation companies to produce compound licorice oral solutions. It offers Qilian Shan oxytetracycline tablets to prevent and treat a range of diseases in chickens, turkeys, cattle, swine, and human; and Qilian Shan oxytetracycline APIs for pharmaceutical companies to manufacture medications. In addition, the company offers TCMD products, such as Ahan antibacterial paste to treat refractory chronic skin diseases; heparin products, including heparin sodium preparations for pharmaceutical companies to produce medications for cardiovascular diseases, cerebrovascular diseases, and hemodialysis; and Zhu Xiaochang sausage casings, which are natural food products for culinary application. Further, it provides Xiongguan organic fertilizers to improve crop yield and soil's chemical properties and reduce soil compaction; and Xiongguan organic-inorganic compound fertilizers to increased plant growth. The company was formerly known as Qilian International Holding Group Limited and changed its name to BGM Group Ltd in October 2024. BGM Group Ltd was incorporated in 2019 and is based in Chengdu, the People's Republic of China.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AAug Wrap: What is the dividend yield of Invesco High Income Trust II - 2025 Key Lessons & Capital Efficiency Focused Ideas baoquankhu1.vn
Read more →Quarterly Risk: Whats the beta of GSHD stock - July 2025 Update & Reliable Entry Point Trade Alerts baoquankhu1.vn
Read more →Showing 2 of 10
(Last Updated 2024-03-31)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Qilian International Holding Group Limited
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-12-31
EPS Actual
—
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2024-03-31)
(Last Updated 2024-03-31)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2024-03-31)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2024-03-31)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.